Vanina de Verneuil sold $32k of VIR
EVP and General Counsel at Vir Biotechnology, Inc.. 3,750 shares at an average of $8.62, traded Nov 1, 2024, filed Nov 5, 2024.
Score components
- +15RoleOfficer
- +5Trade size$32k at market
- 0Share of holdings soldSold 5.8% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -17.3%, 3m +0.6%, 6m -41.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-045387, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | SOpen-market sale Common Stock10b5-1 | -1,403 | $7.20 | $10k | 63,717 | Nov 5, 2024 |
| Nov 5, 2024 | SOpen-market sale Common Stock10b5-1 | -2,347 | $9.47 | $22k | 61,370 | Nov 5, 2024 |
Related signals
Other insiders at Vir Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Vir Biotechnology, Inc. | Vicki L Sato director | $110k 22,000 shares | -2% | |
| 5Weak | Vir Biotechnology, Inc. | Vicki L Sato director | $110k 22,000 shares | -2% | |
| 10Weak | Vir Biotechnology, Inc. | Mark Eisner EVP and Chief Medical Officer | $57k 10,382 shares | -9% | |
| 13Weak | Vir Biotechnology, Inc. | Vicki L Sato director | $112k 22,000 shares | -2% | |
| 0Weak | Vir Biotechnology, Inc. | Janet Napolitano director | $16k 3,200 shares | -16% | |
| 22Weak | Vir Biotechnology, Inc. | Marianne De Backer Chief Executive Officer | $474k 79,712 shares | -9% | |
| 24Weak | Vir Biotechnology, Inc. | Marianne De Backer Chief Executive Officer | $152k 16,122 shares | -2% | |
| 19Weak | Vir Biotechnology, Inc. | Ann M. Hanly EVP & Chief Technology Officer | $134k 14,168 shares | -11% | |
| 15Weak | VIRsell Vir Biotechnology, Inc. | Vanina de Verneuil EVP and General Counsel | $625 76 shares | -0% | |
| 1Weak | Vir Biotechnology, Inc. | Vanina de Verneuil EVP and General Counsel | $44k 4,397 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.